Last 12 months
Inside the activity.
0 purchase rows · 63 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 29 |
| Jan 2026 | 0 | 10 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 06, 2023 Filed Jul 10, 2023 17:16 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 42.5349 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041946 · doc4.xml · derivative · entry 9 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,998.1882 Underlying: Common Shares · 42.5349 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 17:16 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 156.0265 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041946 · doc4.xml · derivative · entry 8 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,002.5687 Underlying: Common Shares · 156.0265 shares Expires 2025-02-21 F9 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units (the "2020-2 PBRSUs") granted to the Reporting Person. The 2020-2 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 17:16 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 201.6087 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041946 · doc4.xml · derivative · entry 7 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,430.4939 Underlying: Common Shares · 201.6087 shares Expires 2025-02-21 F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units (the "2020-1 PBRSUs") granted to the Reporting Person. The 2020-1 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 17:16 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 48.6442 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041946 · doc4.xml · derivative · entry 6 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,859.7096 Underlying: Common Shares · 48.6442 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F6 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 17:16 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 415.2997 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041946 · doc4.xml · derivative · entry 4 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,564.8038 Underlying: Common Shares · 415.2997 shares Expires 2024-02-22 F5 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units (the "2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs have a performance period ending December 31, 2021 and will vest on February 22, 2024, which is the fifth anniversary of the grant date. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 17:16 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 70.2936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041946 · doc4.xml · derivative · entry 3 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,912.6787 Underlying: Common Shares · 70.2936 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F4 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:17 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantPerformance Share Units · Derivative | 318.8721 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041947 · doc4.xml · derivative · entry 9 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,966.7573 Underlying: Common Shares · 318.8721 shares Expires 2026-02-22 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:17 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantRestricted Share Units · Derivative | 65.4307 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041947 · doc4.xml · derivative · entry 8 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,226.9186 Underlying: Common Shares · 65.4307 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:17 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantPerformance Share Units · Derivative | 295.263 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041947 · doc4.xml · derivative · entry 7 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,637.4576 Underlying: Common Shares · 295.263 shares Expires 2025-02-25 F9 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:17 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantRestricted Share Units · Derivative | 51.2766 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041947 · doc4.xml · derivative · entry 6 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,230.9315 Underlying: Common Shares · 51.2766 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F8 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:17 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantPerformance Share Units · Derivative | 113.1653 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041947 · doc4.xml · derivative · entry 5 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,958.3633 Underlying: Common Shares · 113.1653 shares Expires 2024-12-15 F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021-2 PBRSUs") granted to the Reporting Person. The 2021-2 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on December 15, 2024, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:17 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantRestricted Share Units · Derivative | 75.4435 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041947 · doc4.xml · derivative · entry 4 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,638.9089 Underlying: Common Shares · 75.4435 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2022, December 15, 2023 and December 15, 2024. F6 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2022, December 15, 2023 and December 15, 2024. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:17 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantPerformance Share Units · Derivative | 114.1335 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041947 · doc4.xml · derivative · entry 3 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,094.8916 Underlying: Common Shares · 114.1335 shares Expires 2024-09-01 F4 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021-1 PBRSUs") granted to the Reporting Person. The 2021-1 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on September 1, 2024, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:17 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantRestricted Share Units · Derivative | 57.5364 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041947 · doc4.xml · derivative · entry 2 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,113.6748 Underlying: Common Shares · 57.5364 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F3 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F3 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:11 UTC |
DOYLE J PATRICKDirector · Executive Chairman
|
GrantPerformance Share Units · Derivative | 5,446.1667 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041939 · doc4.xml · derivative · entry 4 DOYLE J PATRICK · CIK 0001337160 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 768,008.5218 Underlying: Common Shares · 5,446.1667 shares Expires not disclosed F5 · derivative.exercise_price: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending March 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. F5 · derivative.exercise_date: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending March 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. F5 · derivative.expiration_date: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending March 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:11 UTC |
DOYLE J PATRICKDirector · Executive Chairman
|
GrantRestricted Share Units · Derivative | 3,630.7779 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041939 · doc4.xml · derivative · entry 3 DOYLE J PATRICK · CIK 0001337160 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 512,005.6812 Underlying: Common Shares · 3,630.7779 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest in equal installments on November 21, 2023, November 21, 2024, November 21, 2025, November 21, 2026 and November 21, 2027. F4 · derivative.expiration_date: These restricted share units vest in equal installments on November 21, 2023, November 21, 2024, November 21, 2025, November 21, 2026 and November 21, 2027. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:15 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 239.154 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041944 · doc4.xml · derivative · entry 18 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,725.0679 Underlying: Common Shares · 239.154 shares Expires 2026-02-22 F16 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:15 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 103.3382 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041944 · doc4.xml · derivative · entry 17 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,572.5602 Underlying: Common Shares · 103.3382 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F15 · derivative.exercise_date: The restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F15 · derivative.expiration_date: The restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:15 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 258.3598 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041944 · doc4.xml · derivative · entry 16 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,433.4284 Underlying: Common Shares · 258.3598 shares Expires 2025-02-25 F14 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:15 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 95.8389 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041944 · doc4.xml · derivative · entry 15 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,515.0305 Underlying: Common Shares · 95.8389 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F13 · derivative.exercise_date: The restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F13 · derivative.expiration_date: The restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:15 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 155.4456 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041944 · doc4.xml · derivative · entry 14 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,920.6513 Underlying: Common Shares · 155.4456 shares Expires 2024-02-19 F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:15 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 40.5628 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041944 · doc4.xml · derivative · entry 13 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,720.0903 Underlying: Common Shares · 40.5628 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F11 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:15 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 25.5209 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041944 · doc4.xml · derivative · entry 12 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,598.9129 Underlying: Common Shares · 25.5209 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:15 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 201.6087 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041944 · doc4.xml · derivative · entry 11 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,430.4939 Underlying: Common Shares · 201.6087 shares Expires 2025-02-21 F9 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:15 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 60.2487 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041944 · doc4.xml · derivative · entry 10 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,496.1688 Underlying: Common Shares · 60.2487 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F8 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:15 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 415.2997 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041944 · doc4.xml · derivative · entry 8 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,564.8038 Underlying: Common Shares · 415.2997 shares Expires 2024-02-22 F6 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs have a performance period ending December 31, 2021 and will vest on February 22, 2024, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:15 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 71.0329 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041944 · doc4.xml · derivative · entry 7 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,016.9241 Underlying: Common Shares · 71.0329 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:12 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 95.6616 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041940 · doc4.xml · derivative · entry 14 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,490.0272 Underlying: Common Shares · 95.6616 shares Expires 2026-02-22 F14 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest 100% on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:12 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 50.2432 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041940 · doc4.xml · derivative · entry 13 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,085.2092 Underlying: Common Shares · 50.2432 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F13 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F13 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:12 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 110.7246 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041940 · doc4.xml · derivative · entry 12 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,614.1772 Underlying: Common Shares · 110.7246 shares Expires 2025-02-25 F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2022 and to the extent earned will vest 100% on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:12 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 40.5697 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041940 · doc4.xml · derivative · entry 11 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,721.0607 Underlying: Common Shares · 40.5697 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F11 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:12 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 17.9806 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041940 · doc4.xml · derivative · entry 10 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,535.5977 Underlying: Common Shares · 17.9806 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:12 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 58.0021 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041940 · doc4.xml · derivative · entry 9 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,179.3475 Underlying: Common Shares · 58.0021 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:12 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 80.6435 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041940 · doc4.xml · derivative · entry 8 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,372.1976 Underlying: Common Shares · 80.6435 shares Expires 2025-02-21 F9 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:12 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 29.4671 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041940 · doc4.xml · derivative · entry 7 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,155.401 Underlying: Common Shares · 29.4671 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F8 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:12 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 166.1199 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041940 · doc4.xml · derivative · entry 6 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,425.9215 Underlying: Common Shares · 166.1199 shares Expires 2024-02-22 F6 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2024, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:12 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 36.6627 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041940 · doc4.xml · derivative · entry 5 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,170.1009 Underlying: Common Shares · 36.6627 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:14 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 2,160.3798 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041943 · doc4.xml · derivative · entry 16 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 304,652.8269 Underlying: Common Shares · 2,160.3798 shares Expires 2026-02-22 F16 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending May 21, 2028 and to the extent earned will vest on May 28, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:14 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 186.628 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041943 · doc4.xml · derivative · entry 15 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,317.9422 Underlying: Common Shares · 186.628 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F15 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F15 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:14 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 922.7146 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041943 · doc4.xml · derivative · entry 14 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,119.5365 Underlying: Common Shares · 922.7146 shares Expires 2022-02-25 F14 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:14 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 171.6248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041943 · doc4.xml · derivative · entry 13 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,202.2165 Underlying: Common Shares · 171.6248 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F13 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F13 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:14 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 647.6899 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041943 · doc4.xml · derivative · entry 12 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,336.047 Underlying: Common Shares · 647.6899 shares Expires 2024-02-19 F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:14 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 75.7507 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041943 · doc4.xml · derivative · entry 11 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,682.2278 Underlying: Common Shares · 75.7507 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F11 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:14 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 106.3371 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041943 · doc4.xml · derivative · entry 10 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,995.4704 Underlying: Common Shares · 106.3371 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:14 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 1,612.8697 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041943 · doc4.xml · derivative · entry 9 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227,443.9513 Underlying: Common Shares · 1,612.8697 shares Expires 2025-02-21 F9 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:14 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 116.5702 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041943 · doc4.xml · derivative · entry 8 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,438.5116 Underlying: Common Shares · 116.5702 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F8 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:14 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 1,868.8485 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041943 · doc4.xml · derivative · entry 7 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 263,541.6173 Underlying: Common Shares · 1,868.8485 shares Expires 2024-02-22 F6 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2024, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:14 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 110.5777 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041943 · doc4.xml · derivative · entry 6 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,593.4647 Underlying: Common Shares · 110.5777 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:16 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantPerformance Share Units · Derivative | 531.4534 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041945 · doc4.xml · derivative · entry 14 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,944.5954 Underlying: Common Shares · 531.4534 shares Expires 2026-02-22 F13 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance baserd restricted share units to which they relate. Read SEC document |
| July 06, 2023 Filed Jul 10, 2023 21:16 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 112.9591 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041945 · doc4.xml · derivative · entry 13 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,929.2808 Underlying: Common Shares · 112.9591 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.